41 related articles for article (PubMed ID: 8056702)
1. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
[TBL] [Abstract][Full Text] [Related]
3. Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.
Leow YH; Chan RK; Cheong LL; Goh CL; Nadarajah M
Ann Acad Med Singap; 1995 Jul; 24(4):515-8. PubMed ID: 8849179
[TBL] [Abstract][Full Text] [Related]
4. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Wilton LV; Pearce GL; Mann RD
Br J Clin Pharmacol; 1996 Apr; 41(4):277-84. PubMed ID: 8730972
[TBL] [Abstract][Full Text] [Related]
5. Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.
Widjajanto PH; Sumadiono S; Cloos J; Purwanto I; Sutaryo S; Veerman AJ
J Blood Med; 2013; 4():1-9. PubMed ID: 23403504
[TBL] [Abstract][Full Text] [Related]
6. Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome.
Plett PA; Sampson CH; Chua HL; Joshi M; Booth C; Gough A; Johnson CS; Katz BP; Farese AM; Parker J; MacVittie TJ; Orschell CM
Health Phys; 2012 Oct; 103(4):343-55. PubMed ID: 22929467
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer.
Dranitsaris G
Pharmacoeconomics; 1999 Oct; 16(4):343-53. PubMed ID: 10623363
[TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma.
Dranitsaris G; Altmayer C; Quirt I
Pharmacoeconomics; 1997 Jun; 11(6):566-77. PubMed ID: 10173030
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
Davis R; Markham A; Balfour JA
Drugs; 1996 Jun; 51(6):1019-74. PubMed ID: 8736621
[TBL] [Abstract][Full Text] [Related]
11. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
Bow EJ; Louie TJ
Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
[TBL] [Abstract][Full Text] [Related]
13. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
Thabaut A; Meyran M; Fabre R; Dellamonica P; Moreau N
Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
[TBL] [Abstract][Full Text] [Related]
16. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
Postnikov SS
Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
